H.G. Hewitt Drug Discovery Seminar Series - Dr. John MacMillan - University of California, Santa Cruz
The Department of Pharmaceutical Sciences invites you to attend a seminar on Monday, November 5, 2018 from 3:30-4:30pm, Pharmacy/Biology Building (PBB) room 129
John B. MacMillan, PhD, is a faculty member at the University of California, Santa Cruz. His research focuses on the chemical and biological characterization of natural products from marine bacteria with therapeutic potential in oncology. Over the last five years, the MacMillan laboratory has been working on development of platforms to study the mechanisms by which natural products engage with biological systems. His work in natural products spans the development of NMR methods for structural elucidation, medicinal chemistry. He currently leads the Center for High Content Functional Annotation of Natural Products. He was part of a team that developed an inhibitor of hypoxia inducible factor 2-alpha, an analog of which is currently in Phase II clinical trials for the treatment of renal cell carcinoma.
He earned his PhD at the University of California Davis, where his interests in small molecule NMR began by studying the natural products chemistry of marine organisms. He did his postdoctoral work at the Scripps Institution of Oceanography in San Diego with microbial natural products. Prior to UC-Santa Cruz, Dr. MacMillan was on faculty in the Department of Biochemistry at UT Southwestern Medical Center.
Monday, November 5, 2018, 3:30-4:30pm
Pharmacy/Biology Building (PBB) room 129
Host: Dr. Marcy Balunas
For more information, contact: Dr. Marcy Balunas at 860-486-3051